Appointment of Nominated Adviser and Sole Broker

RNS Number : 0102Y
MyCelx Technologies Corporation
04 September 2020
 

4 September 2020 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

("MYCELX" or the "Company")

Appointment of Nominated Adviser and Sole Broker

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, is pleased to announce the appointment of Canaccord Genuity Limited ("Canaccord Genuity") as its Nominated Adviser and Broker with immediate effect.

 

For further information, please contact:

 

 

AIM Rules for Companies disclosure

The following information is disclosed pursuant to Schedule Two Paragraph (g) of the AIM Rules for Companies:

· Tim Eggar is a Director of Shiplake Court Enterprises Limited

· Andre Schnabl is a Director of Doug Smith Production Consultants Inc. and was previously in the last five years a Director of Aldmark Holdings Inc.

· Thomas Lamb is a Director of Pharos Marine Automatic Power Inc.

 

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBCGDCSUGDGGX
UK 100